Pancreatic Cancer Research

ResearcherUniversity of Southern DenmarkNo recent work listed

Stine Brændegaard Winther

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4476-9367; OpenAlex author ID A5009315303. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers

Papers 3

  1. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic c… First author DOI 10.1186/s12885-023-11035-6↗
  2. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic c… First author DOI 10.21203/rs.3.rs-2955930/v1↗
  3. S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma. Co-author DOI 10.1007/s00280-018-3528-5↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Per Pfeiffer · 3 shared papers, 2018–2023 · strength 0.41
  2. Morten Bækbo Ladekarl · 2 shared papers, 2023 · strength 0.32
  3. Louise S. Rasmussen · 2 shared papers, 2023 · strength 0.32
  4. Britta Weber · 2 shared papers, 2023 · strength 0.32
  5. Gabor Istvan Liposits · 2 shared papers, 2023 · strength 0.32
  6. Julia Sidenius Johansen · 2 shared papers, 2023 · strength 0.32
  7. Inna Markovna Chen · 2 shared papers, 2023 · strength 0.32
  8. Sönke Detlefsen · 2 shared papers, 2023 · strength 0.32
  9. Susy Shim · 1 shared paper, 2023 · strength 0.16
  10. Susy Shim · 1 shared paper, 2023 · strength 0.16
  11. Mathilde Weisz Ejlsmark · 1 shared paper, 2018 · strength 0.09
  12. Jon Kroll Bjerregaard · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.